Mwanzo600812 • SHA
add
North China Pharmaceutical Co Ltd
Bei iliyotangulia
¥ 5.28
Bei za siku
¥ 5.23 - ¥ 5.37
Bei za mwaka
¥ 3.83 - ¥ 6.22
Wastani wa hisa zilizouzwa
12.08M
Uwiano wa bei na mapato
114.76
Mgao wa faida
0.19%
Ubadilishanaji wa msingi
SHA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.33B | -15.04% |
Matumizi ya uendeshaji wa biashara | 539.22M | -19.20% |
Mapato halisi | 30.48M | 2,035.14% |
Kiwango cha faida halisi | 1.31 | 2,520.00% |
Mapato kwa kila hisa | — | — |
EBITDA | 362.65M | 6.65% |
Asilimia ya kodi ya mapato | 32.92% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.72B | 15.99% |
Jumla ya mali | 21.71B | 0.92% |
Jumla ya dhima | 15.10B | -0.95% |
Jumla ya hisa | 6.61B | — |
hisa zilizosalia | 1.72B | — |
Uwiano wa bei na thamani | 1.69 | — |
Faida inayotokana na mali | 2.06% | — |
Faida inayotokana mtaji | 2.47% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 30.48M | 2,035.14% |
Pesa kutokana na shughuli | 175.21M | -46.70% |
Pesa kutokana na uwekezaji | -153.19M | 10.80% |
Pesa kutokana na ufadhili | -76.80M | 67.74% |
Mabadiliko halisi ya pesa taslimu | -55.38M | 30.27% |
Mtiririko huru wa pesa | -660.87M | -459.21% |
Kuhusu
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Ilianzishwa
20 Des 1992
Wafanyakazi
10,159
